Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Geng A et al. – Overall, the tolerability level of topical tretinoin was high in this study population, with almost 40% of the tretinoin group reporting no side–effects, and the majority tolerating at least once–daily dosing at 6–month follow–up. High–dose topical tretinoin is feasible for long–term use in this population.

Related Articles

Arsenic trioxide as first-line treatment for acute promyelocytic leukemia
American Journal of Health-System Pharmacy, 10/26/09    Relevance Score: 84%

All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease
Expert Review of Neurotherapeutics, 11/18/09    Relevance Score: 77%

Enlarging vesicular peeling of the palms
The Clinical Advisor, 11/04/09    Relevance Score: 77%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address